R D Hull, J Liang, R Brant. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralArthroplasty, Replacement, Hip/adverse effectsArthroplasty, Replacement, Hip/mortalityArthroplasty, Replacement, Knee/adverse effectsArthroplasty, Replacement, Knee/mortalityBenzimidazoles/administration & dosageBenzimidazoles/adverse effectsDabigatranDouble-Blind MethodDrug Administration ScheduleElective Surgical ProceduresEnoxaparin/administration & dosageEnoxaparin/adverse effectsEvidence-Based MedicineFibrinolytic Agents/administration & dosageFibrinolytic Agents/adverse effectsHemorrhage/chemically inducedHumansInjections, SubcutaneousMeta-Analysis as TopicPyridines/administration & dosagePyridines/adverse effectsRandomized Controlled Trials as TopicReproducibility of ResultsResearch DesignRisk AssessmentRisk FactorsTreatment OutcomeVenous Thromboembolism/etiologyVenous Thromboembolism/mortalityVenous Thromboembolism/prevention & control
Substances: See more » BenzimidazolesEnoxaparinFibrinolytic AgentsPyridinesDabigatran
Year: 2010 PMID: 20542545 DOI: 10.1016/j.thromres.2010.05.009
Source DB: PubMed Journal: Thromb Res ISSN: 0049-3848 Impact factor: 3.944